Cognitive Protective Effect of Newer Antidiabetic Drugs

计划入组 100 人 · 首次发布于 2022 年 4 月 26 日

Clinical Characteristics and Practice Patterns of Type 2 Diabetes Mellitus Patients Treated With OADs in Japan: Analysis of Medical and Health Care Database of the MDV

计划入组 162,116 人 · 首次发布于 2017 年 3 月 28 日

The Efficacy of Mallya in Type 2 Diabetes Transiting From Oral Antidiabetic Drugs to iGlarLixi

计划入组 40 人 · 首次发布于 2022 年 10 月 24 日

Ertugliflozin(Segluromet, Steglatro, Steglujan)

C₂₂H₂₅ClO₇ · Rx

repurposed anticancer drugs

AHG-255

AARTI DRUGS LIMITED

India

HETERO DRUGS LIMITED

India

Boone Drugs Inc.

United States

Global Antidiabetic Drugs Market Projected to Reach USD 309.84 Billion by 2035, Driven by GLP-1 and SGLT2 Innovation

Gan & Lee's Novel Diabetes Drugs GZR18, GZR4, and GZR101 Achieve Positive Phase 2 Results

SGLT2 Inhibitors Show Promising Results for Elderly with Type 2 Diabetes